Clinical implications of bronchial hyperreactivity.

Clinical implications of bronchial hyperreactivity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical implications of bronchial hyperreactivity. Abstract Text:

B G Simonsson,

Bronchial hyperreactivity may be a primary internal factor needed for the occurrence of asthmatic symptoms when the atopic individual meets with allergens or the non-atopic individual inhales irritants causing inflammatory reactions in the bronchial tree. It can also be a secondary expression of allergy and occupational exposures. The hyperreactivity can be affected by treatment and is therefore a valuable tool to judge experimental studies of background and predictive factors, for follow up of specified airways disease and for treatment and drug effects. It is necessary to collect sufficient background factors and to use proper dose-response studies. We still lack knowledge as to why presumed normal subjects react, is it due to undetected small airways disease? Do we need to measure both sensitivity (as threshold values) and reactivity (as dose response-curves) in all kinds of tests of bronchial reactivity? We need simple ways to test larger populations in prospective studies of workers exposed to occupational irritants in order to solve the problems of primary versus secondary, acquired hyperreactivity.

Clinical implications of bronchial hyperreactivity. Publishing Authors By Initials

BG Simonsson,

For similar respiratory tract diseases: respiratory hypersensitivity research abstracts see: respiratory tract diseases: respiratory hypersensitivity research

PUBMED ID PMID:

MEDLINE DATE:

Clinical implications of bronchial hyperreactivity. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European journal of respiratory diseases. Suppleme

VOLUME: 106

Page Numbers: 7-18

Journal Abbreviation:

ISSN: 0106-4347

DAY: 21

MONTH: 02

YEAR: 1980

Clinical implications of bronchial hyperreactivity. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8010618

Clinical implications of bronchial hyperreactivity. Keywords Mesh Terms:

KEYWORDS: Respiratory Hypersensitivity

MESH TERMS: diagnosis

Chemical & Substance for Abstract: Clinical implications of bronchial hyperreactivity. Information

Substance Name: Histamine

Registry Number: 51-45-6

Grant and Affiliation Information for Clinical implications of bronchial hyperreactivity.

AFFILIATION:

Country: DENMARK

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Respir Dis Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical implications of bronchial hyperreactivity Related Publications

• A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens.
• Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies.
• Airway hyperreactivity. Definition and short review.
• Anatomical and pathophysiological considerations in aerosol therapy.
• Anticholinergic drugs--a review.
• Bronchial hyperreactivity.
• Bronchial reactivity in occupational asthma and bronchitis.
• Bronchial reactivity in relation to occupational bronchitis and asthma.
• Chronic cough and expectoration in patients with asthma and in patients with alpha1-antitrypsin deficiency.
• Clinical implications of bronchial hyperreactivity.
• Continuous and intermittent exposure to ethanol: effect on NG 108-15 cell membrane phospholipids.
• Evaluation of ethanol effects on PLC signal transduction pathways using cell lines of neuronal origin.
• Identification and characterization of an essential telomeric repeat binding factor in fission yeast.
• Method evaluation of Fusarium DNA extraction from mycelia and wheat for down-stream real-time PCR quantification and correlation to mycotoxin levels.
• Non-specific bronchial hyperreactivity: correlation to asthma and modifying factors.
• Optimal adaptive design in clinical drug development: a simulation example.
• Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.
• Pulmonary gas exchange at rest and during exercise in chronic bronchitis.
• Total nucleated cell differential for blood and bone marrow using a single tube in a five-color flow cytometer.
• Treatment of respiratory failure.